Heba Abdel-Razik Sayed Hussein

South Egypt Cancer Institute

Assiut University

Department
Department of Pediatric Oncology
Fax No
N/A
Email:
hebadina2007@yahoo.com
MIS Email
hebadina2007@aun.edu.eg
Mobile
01004246422
Office
N/A - 04252
Google Scholar
google_scholar
M.D. In () , , 2008

Professor South Egypt Cancer Institute, ِِAssiut University , 2018

Associate Professor South Egypt Cancer Institute, ِِAssiut University , 2013

Lecturer South Egypt Cancer Institute, Assiut University , 2008

Assistant Lecturer South Egypt Cancer Institute, Assiut University , 2001

Demonstrator South Egypt Cancer Institute, Assiut University , 2001

Head South Egypt Cancer Institute, Assiut University ,since 2019-06-09
# Title Research Year
1 High Dose Methotrexate Induced Toxicity in Children with Hematological Malignancy: Incidence and Relation to MTX Level 2024
2 High Dose Methotrexate Induced Toxicity in Children with Hematological Malignancy: Incidence and Relation to MTX Level 2024
3 Neutropenic Fever in Pediatric Patients with Cancer in South Egypt: A Report from a Single Institute 2022
4 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute 2021
5 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute 2021
6 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute 		2019
7 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute 		2019
8 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute 		2018
9 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute 		2018
10 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources 2018
11 Clinicopathological pattern and outcome of pediatric malignant ovarian germ cell tumors: South Egypt Cancer Institute experience 2017
12 Clinicopathological pattern and outcome of pediatric malignant ovarian germ cell tumors: South Egypt Cancer Institute experience 2017
13 Can Pediatric Risk of Mortality Score (PRISM III) Be Used Effectively in Initial Evaluation and Follow-up of Critically Ill Cancer Patients Admitted to Pediatric Oncology Intensive Care Unit (POICU)? A Prospective Study, in a Tertiary Cancer Center in Egy 2017
14 The Outcome of Critically Ill Pediatric Cancer Patients Admitted to the Pediatric Intensive Care Unit in a Tertiary University Oncology Center in a Developing Country: A 5-Year Experience. 2016
15 The Outcome of Critically Ill Pediatric Cancer Patients Admitted to the Pediatric Intensive Care Unit in a Tertiary University Oncology Center in a Developing Country: A 5-Year Experience. 2016
16 Transdermal Fentanyl for Cancer Pain
Management in Opioid-Naive Pediatric
Cancer Patients 		2016
17 Transdermal Fentanyl for Cancer Pain
Management in Opioid-Naive Pediatric
Cancer Patients 		2016
18 Pattern of Pediatric Tumors at Pediatric Department in South Egypt Cancer Institute 2016
19 Prognostic implications of expression of the Wilms tumor 1 (WT1) gene in acute leukemia (Experience from South Egypt) 2015
20 Castleman's Disease as a Rare Differential Diagnosis of Lymphadenopathy: 2 Case Reports and Review of Literature 2015
21 Fms-Like Tyrosine Kinase 3 expression in Childhood Acute lymphoblastic Leukemia at South Egypt Cancer Institute, Assiut University, Egypt, 2014
22 Fms-Like Tyrosine Kinase 3 expression in Childhood
Acute lymphoblastic Leukemia at South Egypt Cancer
Institute, Assiut University, Egypt 		2014
23 Fms-Like Tyrosine Kinase 3 expression in Childhood
Acute lymphoblastic Leukemia at South Egypt Cancer
Institute, Assiut University, Egypt 		2014
24 Fms-Like Tyrosine Kinase 3 expression in Childhood
Acute lymphoblastic Leukemia at South Egypt Cancer
Institute, Assiut University, Egypt 		2014
25 Fms-Like Tyrosine Kinase 3 expression in Childhood
Acute lymphoblastic Leukemia at South Egypt Cancer
Institute, Assiut University, Egypt













 		2014
26 Fms-Like Tyrosine Kinase 3 expression in Childhood
Acute lymphoblastic Leukemia at South Egypt Cancer
Institute, Assiut University, Egypt
 		2014
27 Sacrococcygeal tumors: clinical characteristics and outcome of pediatric patients treated at South Egypt Cancer Institute. A retrospective analysis. 2013
28 Combined Modality Therapy of Pediatric Wilms' Tumor in Upper Egypt: A Retrospective Study 2012
29 Risk Stratification Treatment of Pediatric Rhabdomyosarcoma: South Egypt Cancer Institute experience 2012
30 Role of Surgery in Stages II and III Pediatric Abdominal Non-Hodgkin Lymphoma: A 5-Years Experience 2011
31 Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: A retrospective study 2010
32 Long-term Follow-up of Infantile Wilms Tumor Treated According to International Society of Pediatric Oncology Protocol: Seven Years' Follow-up 2010
1- Mahmoud Motaz Mohammed Ibrahim , Study of Cognitive Dysfunction in Patients with Acute Lymphoblastic Lukemia who Received CNS Prophylaxis ,2012-06-30
supervisor: Mohammed Hamdy Ghazaly, Amany Mohammed Ali, Heba Abdel Razik Sayed

2- Heba Hassan Husien Hassan , Pattern of Pediatric Solid Tumors in Pediatric Unite at Sohag Cancer Institute ,2012-06-30
supervisor: Mohammed Mahmoud Hamdy Ghazaly, Amany Mohammed Ali, Heba Abdel Razic Sayed

3- Salah Fargali Osman Ahmad , Assessment Of Child With Suspected Cancer ,2012-06-30
supervisor: Mohamed Hamdy Ghazaly, Amany Mohamed Ali, Heba Abde IRazik Sayed

4- Yousra Sayed Abdel Rahman , Pattern of pediatric Solid Tumors at south Egypt Cancer Institute ,2012-01-01
supervisor: Mohammed Hamdy Ghazaly, Amany Mohamed Ali, Hebaabdelraziq Sayed

الجمعيات العلمية و النقابات :